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Background-—China faces a substantial burden from cardiometabolic diseases, but longitudinal studies on a wide range of
cardiometabolic risk factors are limited. We examined the 6-year incidence of 8 cardiometabolic risk factors in a diverse,
population-based cohort.
Methods and Results-—In the China Health and Nutrition Survey, anthropometry, blood pressure, and fasting blood samples were
collected from 9621 adults (47.6% men) aged 18 to 99 years in 2009 who were followed into 2015. Using inverse probability
weights to account for loss to follow-up, we estimated the 6-year incidence of 8 cardiometabolic risk factors and compared the
incidence of each risk factor across age groups using inverse probability–weighted sex-stratified logistic regression models.
Incidence was noted for the following cardiometabolic risk factors during 2009–2015: hypertension (systolic/diastolic blood
pressure ≥140/90 mm Hg; men: 29.2%; women: 24.9%), high waist circumference/height ratio (≥0.5; men: 42.4%; women:
43.8%), and high total to HDL (high-density lipoprotein) cholesterol ratio (≥5; men: 17.0%; women: 14.5%). Older men and women
(aged ≥65 years) had the highest incidence of hypertension. Incidence of high waist circumference/height ratio and high LDL (low-
density lipoprotein) cholesterol (≥130 mg/dL) was highest among older (aged ≥65 years) women, whereas incidence of
overweight (body mass index ≥25) and high triglycerides (≥150 mg/dL) was highest among younger (aged 18–35 and 35–
50 years) men.
Conclusions-—We found increases in cardiometabolic risk among Chinese adults during this recent, short, 6-year period that are
higher than previous studies in China. The higher incidence of overweight and elevated dyslipidemia markers in younger versus
older men portends an increasing burden of cardiometabolic diseases in China as the younger population ages. ( J Am Heart
Assoc. 2019;8:e011368. DOI: 10.1161/JAHA.118.011368.)
Key Words: cardiovascular disease risk factors • Chinese adults • incidence
T he burden of cardiometabolic risk in China has expandedrapidly. Mortality from cardiometabolic diseases such as
type 2 diabetes mellitus, cardiovascular disease (CVD), and
coronary heart disease has increased,1 and CVD is now the
leading cause of death.2 Moreover, the prevalence of major
cardiometabolic risk factors in Chinese adults has risen
considerably: combined overweight and obesity increased
from 13.4% in 1993 to 26.4% in 20093; abdominal obesity
increased from 18.6% in 1993 to 37.4% in 20093; hyperten-
sion increased from 14.5% in 1991 to 21.4% in 20094; and
type 2 diabetes mellitus increased from 9.7% in 2007 to
11.6% in 2010.5,6 By 2010, China already had the largest
absolute disease burden of diabetes mellitus5 and hyperten-
sion7 in the world. Approximately 114 million Chinese adults
had diabetes mellitus and 265 million had hypertension in
2010. Changes in social and behavior factors, such as
population aging, rapid urbanization, and unhealthy lifestyles
characterized by physical inactivity and poor diet2,8 have
contributed to the high cardiometabolic risk in Chinese adults.
Although others have reported the prevalence of a wide
range of cardiometabolic risk factors in Chinese adults,4,5,9–11
few longitudinal studies have investigated the incidence of
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cardiometabolic risk factors, and most were limited to
overweight,12 hypertension,13,14 and type 2 diabetes melli-
tus15–20 and reflected risk in 1 region.15–17 Fundamental gaps
exist in knowledge about the emergence of cardiometabolic
risks in the full population and how these risks differ by sex
and age, and this lack limits the ability to plan for the
reduction of disease and disability as the current population
ages. Using the most recent rounds of fasting blood collection
in the longitudinal and population-based CHNS (China Health
and Nutrition Survey; 2009 and 2015), we estimated the sex-
and age-specific 6-year incidence of overweight; high waist
circumference (WC)/height ratio (WHR); hypertension; type 2
diabetes mellitus; and elevated high sensitivity CRP (C-
reactive protein), LDL-C (low-density lipoprotein cholesterol),
triglycerides, and ratio of total cholesterol (TC) to HDL-C high-
density lipoprotein cholesterol in 9621 Chinese adults aged
18 to 99 years from 2009 to 2015, with inverse probability
weighting (IPW) to account for loss to follow-up.21.
Methods
The data, analytic methods, and study materials are available to
other researchers for purposes of reproducing the results or
replicating the procedure. TheCHNSdata can be accessed at the
CHNS website (https://www.cpc.unc.edu/projects/china).
China Health and Nutrition Survey
The CHNS is a longitudinal study of 388 communities within
15 provinces and cities of China. The CHNS began in 1989,
with subsequent surveys every 2 to 4 years for a total of 10
rounds of surveys through 2015, with fasting blood collected
in 2009 and 2015. Individuals from 3 megacities (autonomous
cities with populations of more than 20 million people) and 3
of the 12 provinces were added to the sample after 2009 and
thus cannot contribute to incidence estimates from 2009 and
2015. Consequently, only individuals in the 9 primary
provinces (Liaoning, Shandong, Heilongjiang, Henan, Jiangsu,
Hubei, Hunan, Guizhou, and Guangxi), who were followed from
2009 to 2015, were included in this analysis. The CHNS was
designed to examine rapid urbanization and its impacts on
health across diverse communities in China.22 The study used
a multistage, random-cluster design to select a stratified
probability sample to capture rural/urban contrasts within
each province. The CHNS provinces reflect 47% of the
Chinese population, with sample selection focused on repre-
sentation of urban and rural communities across China.23 The
CHNS provinces vary in industrialization, lifestyle, income, and
population density as well as geography, economy, resources,
health, and behaviors, capturing the diversity of China across
rural and urban areas and over time. More detailed survey
procedures have been described elsewhere.22 All participants
signed informed consent before participating in the survey.
The study met the standards for the ethical treatment of
participants and was approved by the institutional review
boards of the University of North Carolina at Chapel Hill, the
China–Japan Friendship Hospital, the Ministry of Health of
China, and the Institute of Nutrition and Health, Chinese
Center for Disease Control and Prevention.
Analytic Sample
The 2009 CHNS included 12 133 participants. Participants
were eligible for the analytic sample if they were between the
ages of 18 and 99 years and had at least 1 of the following
measures in 2009: body mass index (BMI), WC and height,
systolic blood pressure (SBP) and diastolic blood pressure
(DBP), CRP, HbA1c or fasting glucose, fasting TC and HDL-C,
fasting LDL-C, or fasting triglycerides. These criteria resulted
in an eligible sample of 9699 participants. We excluded
women pregnant at the time of the 2009 examination (n=62)
and participants missing any of the following covariates in
2009: age, sex, educational attainment, per capita household
income, household asset score, and urbanization index
(n=16). These criteria resulted in an analytic sample of
9621 participants for the 2009 cross-sectional prevalence
sample. Of these 9621 participants, we excluded 3920 who
were lost to follow-up between 2009 and 2015 and 2
participants who were pregnant at the 2015 physical
Clinical Perspective
What Is New?
• Our study adds incidence data for a wide range of
cardiometabolic risk factors in a diverse, population-based
cohort in China with a recent time frame compared with
previous studies focused on single cardiometabolic risk
factors.
• We found an increase in the incidence of cardiometabolic
risk factors during the past decade in China.
What Are the Clinical Implications?
• Understanding patterns of cardiometabolic risk in the
understudied Asian population is important for Asians
across the globe, including those in the United States.
• The distinct patterns of cardiometabolic risk by sex and age
group suggest that sex- and age-specific strategies may be
needed to address cardiometabolic diseases in Asian
populations.
• The higher incidence of overweight and elevated dyslipi-
demia markers in younger versus older men portends an
increasing future burden of cardiometabolic diseases, which
is a major concern for the Chinese healthcare system, and
understanding the cardiometabolic risk in China during rapid
urbanization has huge implications for other low- to middle-
income countries experiencing rapid urbanization.
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examination for our 2015 cross-sectional prevalence sample
(n=5699). Of these 5699 participants, we excluded individuals
who had cardiometabolic risk factors above thresholds of risk
at baseline (2009) for incidence analysis of cardiometabolic
risk factors, resulting in an incidence sample of 5540
participants (ie, participants in the incidence analysis had to
be free of baseline cardiometabolic risk to generate incidence
statistics). The sample flow is shown in Figure 1.
Outcome Measures
Wemeasured height without shoes to the nearest 0.1 cm using
portable stadiometers, weight to the nearest 0.1 kg in light
clothing using calibrated beam scales, and WC to the nearest
0.1 cm at midway between the lowest rib and iliac crest using
nonelastic tape. According to the World Health Organization
(WHO), we defined overweight as BMI (kg/m2) ≥25.24 In the
sensitivity analysis, we defined overweight as BMI ≥23 based on
the Asian cutoff point24 to examine whether different over-
weight definitions resulted in different patterns of overweight
prevalence and incidence by sex and age groups. We defined
high WHR as WHR ≥0.5, the standard cut point for abdominal
obesity,25 shown to predict CVD and diabetes mellitus.
Blood pressure was measured 3 times on the right arm
after 10 minutes of seated rest by trained examiners using
standard mercury sphygmomanometers. We defined hyper-
tension as the average of 3 measurements of SBP/DBP
≥140/90 mm Hg according to WHO26 or self-reported use of
antihypertension medications. Blood was collected by
venipuncture (12 mL) following 8-hour fasting and was
immediately tested for serum glucose using the GOD-RAP
method (Randox Laboratories). The remaining samples were
immediately frozen, stored, and processed in a national
central laboratory in Beijing (medical laboratory accreditation
certificate ISO 15189:2007) with strict quality control. HbA1c
was measured by an automated glycohemoglobin analyzer
with a high-performance liquid chromatography system
(model HLC-723 G7; Tosoh Corp). We defined type 2 diabetes
mellitus as HbA1c ≥6.5% or fasting glucose ≥126 mg/dL
according to the American Diabetes Association27 or self-
reported use of diabetes mellitus medication. CRP was
measured by the immunoturbidimetric method with Denka
Seiken reagents (Hitachi 7600 automated analyzer). We
defined high CRP as >3 and ≤10 mg/L, a marker of chronic
low-grade inflammation28 and a stronger risk factor for
coronary heart disease events,29 and excluded individuals
with CRP >10 mg/L in the estimations of the prevalence and
incidence of high CRP because CRP>10 mg/L indicates acute
infection.28 HDL-C, LDL-C, and triglycerides were estimated
using the glycerol–phosphate oxidase method and the
polyethylene glycol–modified enzyme assay by determiner
reagents (Kyowa Medex) using a Hitachi 7600 automated
analyzer. We defined TC/HDL-C ≥5, triglycerides ≥150 mg/
dL, and LDL-C ≥130 mg/dL as high TC/HDL-C,30,31 high
triglycerides,32 and high LDL-C,32 respectively, which are
dyslipidemia markers.
Predictors of Loss to Follow-up for IPW Analysis
in the 2015 Cross-sectional and 2009–2015
Incidence Samples
The following covariates from the 2009 survey were used to
derive the IPW, predicting loss to follow-up from 2009 to 2015:
age, sex, urbanization index, educational attainment, per capita
household income, household asset score, and province. We
used a validated, community-level, multidimensional, 12-
component, urbanization index33 derived from household and
community survey questions at each wave. We defined low,
medium, and high urbanization based on tertiles of urbanization
index in 2009. We categorized age in 2009 into 4 groups (18 to
35, 35 to 50, 50 to 65, ≥65 years) and dichotomized
educational attainment as of 2009 to less than high school
and high school or more. We imputed missing baseline
education (n=46) based on education reported in other survey
years, assuming it rarely changed during adulthood. We
generated a household asset score representing the number
of items from the following list: color TV, refrigerator,
microwave oven, electric cooking pot, air conditioner, electric
fan, computer, camera, telephone, cell phone, and video disk
player. These items represented household wealth regardless
of rural or urban area. For individuals missing household
information (number of household members) in 2009, we
imputed household size if it was the same in the 2 adjacent
survey years (2006 and 2011, n=118) and subsequently
excluded those with missing 2009 household size and unequal
household sizes between 2006 and 2011 from the analysis due
to missing covariates. We estimated income based on detailed
reports of all income activities of all household members and
imputed missing household income in 2009 (n=132) using
single imputation from observed province, urbanicity, house-
hold asset score, education attainment, and household size in
2009 using Poisson regression. We defined low, medium, and
high income levels using tertiles of per capita household income




We conducted all statistical analyses using Stata 14 (Stata-
Corp). We present continuous variables as mean (SD) and
categorical variables as proportion (95% CI). We calculated
crude 2009 prevalence of cardiometabolic risk factors and used
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Figure 1. Sample flow diagram. *Total sample listed, note that specific cardiometabolic phenotypes have
different sample sizes to allow for missingness across phenotypes. †We excluded 159 participants who were
present in 2009 and 2015 but were above cardiometabolic risk thresholds for all available phenotypes at
baseline (2009), thus they were excluded from all incidence analyses. ‡Total sample listed, note that specific
cardiometabolicphenotypeshavedifferentsamplesizesduetodifferencesacrossthesephenotypesinnumbers
of participants above baseline cardiometabolic risk thresholds for each phenotype (eg, 3810 participants had
BMI<25atbaseline and thuswereeligible foranalysisof the incidenceofoverweight). BMI indicatesbodymass
index;CHNS,ChineseHealth andNutritionSurvey;CRP,high sensitivityC-reactiveprotein;DBP,diastolic blood
pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP systolic
blood pressure; TC, total cholesterol; TG, triglycerides; WHR, waist circumference/height ratio.
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sex-stratified logistic regression to compare the 2009 preva-
lence of each cardiometabolic risk factor across age groups.
Incidence
In our longitudinal analysis, we used IPW to control for loss to
follow-up in the period between 2009 and2015 to calculate IPW
prevalence of cardiometabolic risk factors in 2015, which
comprised persistent cardiometabolic risk (ie, risk factors
above cardiometabolic risk thresholds in 2009 that remained
above threshold in 2015) and incident cardiometabolic risk (ie,
risk factors below cardiometabolic risk thresholds in 2009 but
increased above cardiometabolic thresholds in 2015), as well
as incidence of cardiometabolic risk factors in the period
between 2009 and 2015. To derive IPW, we used a probit model
to create IPW for each cardiometabolic risk factor to account for
loss to follow-up. The probability of having the risk factor data in
2015, given that the risk factor was measured in 2009, was
predicted by the following baseline characteristics based on a
priori hypotheses: sex, age, age squared, sex9age interaction,
sex9age squared interaction, urbanization level, educational
attainment, income level, household asset score, and province.
We used a probit model to examine the associations of the
above baseline characteristics with loss to follow-up from 2009
to 2015 for each cardiometabolic risk factor. We added each
cardiometabolic risk factor to this model to confirm that
cardiometabolic risk factors in 2009 did not predict the
probability of loss to follow-up after adjustment for the baseline
characteristics listed. However, the final IPW model did not
include these cardiometabolic risk factors, only the covariates
specified a priori. We used IPW and sex-stratified logistic
regression to test the differences in 2015 prevalence of
cardiometabolic risk factors (including proportions of persis-
tent and incident cardiometabolic risk) and 2009–2015
incidence of cardiometabolic risk factors across age groups.
Total number of cardiometabolic risk factors
In a subsample of participants with all cardiometabolic risk
factor data in the 2009 and 2015 CHNS surveys (n=3260), we
estimated the average total number of cardiometabolic risk
factors above risk factor thresholds for each sex and age group
to test whether the total number of cardiometabolic risk
factors increased from 2009 to 2015, using a paired t test.
Results
Crude Prevalence of Cardiometabolic Risk
Factors in 2009
The 2009 crude prevalence of overweight, high WHR, hyper-
tension, high CRP, high LDL-C, and high triglycerides was high
across the full sample (Table) and varied by age group in both
men and women (P value across age groups <0.001; Figure 2,
Table S1). Thehighestprevalenceofoverweight,highTC/HDL-C,
and high triglycerides occurred in middle-aged men (aged 35–
50 years)andwomenaged≥50 years. In thesensitivityanalysis,
theprevalenceofoverweightbyAsiandefinition (BMI≥23)24also
differed by age group (P<0.001).
Loss to Follow-up
In 2015, 3920 (40.7%) adults in the 2009 analysis sample were
lost to follow-up (Figure 1). Participants who were male,
younger, lived in more urbanized areas, and had completed at
least a high school education at baseline were more likely to be
lost in 2015 (Table S2). The likelihood of loss to follow-up varied
across provinces. Although we found no evidence that baseline
household asset score and income level were associated with
loss to follow-up, we retained these variables in the IPW model
due to a priori assumptions. Moreover, no evidence was found
that baseline cardiometabolic risk factors were associated with
loss to follow-up after adjustment for other covariates.
IPW Prevalence of Cardiometabolic Risk Factors
in 2015
The IPW 2015 prevalence of all cardiometabolic risk factors
among individuals in the 2009 analysis sample differed across
age groups (P<0.05) except for high TC/HDL-C in men
(Figure 3, Table S3). The prevalence of high CRP was highest
among young men (aged 18–35 years; 13.4% [95% CI, 7.8–
22.3%]) and old men (aged ≥65 years; 13.7% [95% CI, 10.9–
17.0%]), and the prevalence of high triglycerides was highest in
men aged 35–50 years (39.2% [95% CI, 34.1–44.5%]), whereas
the prevalence of overweight was lowest in men aged
≥65 years (32.7% [95% CI, 29.3–36.2%]). The proportions with
persistent (ie, present in both years) overweight, highWHR, and
high LDL-C were higher in older versus younger men and
women (P<0.01), whereas the proportions of incident over-
weight and LDL-C inmen and incident highWHR in womenwere
higher in younger versus older participants (P<0.01).
IPW Incidence of Cardiometabolic Risk Factors
From 2009 to 2015
We estimated the IPW-adjusted incidence of each car-
diometabolic risk factor from 2009 to 2015 among individuals
with cardiometabolic risk below cardiometabolic risk thresh-
olds at baseline (2009). The IPW-adjusted incidence of high
WHR, hypertension, type 2 diabetes mellitus, and dyslipidemia
markers differed across age groups in women (P<0.01;
Figure 4, Table S4), with particularly high incidence of high
WHR (61.7% [95% CI, 50.8–71.5%]), hypertension (50.4%
[43.6–57.2%]), and high LDL-C (35.2% [95% CI, 27.6–43.6%])
in women aged ≥65 years. The incidence of overweight,
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hypertension, high LDL-C, and high triglycerides differed
across age groups in men (P<0.05), with the highest incidence
of overweight in young men (aged 18–35 years; 29.0% [95%
CI, 23.3–35.4%]) and the highest incidence of high triglyc-
erides in men aged 18 to 35 years (22.4% [95% CI,
15.3–31.6%]) and 35–50 years (23.9% [95% CI, 19.5–
28.8%]). The incidence of overweight defined by Asian cutoff
point24 (BMI ≥23) and by WHO cutoff point (BMI ≥25) had
similar patterns by sex and age groups.
Total Number of Cardiometabolic Risk Factors
In a subsample of participants who were seen in 2009 and
2015 and had data for all cardiometabolic risk factors
(n=3206; Table S5), the average total number of car-
diometabolic risk factors above risk factor thresholds
increased from 2.23 (SD: 1.70) in 2009 to 2.62 (SD:
1.76) in 2015 in men (P<0.001) and from 2.27 (SD: 1.74)
in 2009 to 2.60 (SD: 1.81) in 2015 in women (P<0.001).
The age group–specific average number of cardiometabolic
Table. Characteristics of Participants in the 2009 CHNS
Men, n=4584 Women, n=5037 Total, n=9621
Age, y, mean (SD) 50.2 (15.4) 50.9 (15.3) 50.6 (15.3)
Age distribution, % (95% CI)
18–35 y 17.3 (16.2–18.4) 15.6 (14.6–16.6) 16.4 (15.7–17.1)
35–50 y 31.8 (30.5–33.2) 32.6 (31.3–33.9) 32.2 (31.3–33.2)
50–65 y 33.1 (31.8–34.5) 33.3 (32.0–34.6) 33.2 (32.3–34.2)
≥65 y 17.8 (16.7–18.9) 18.5 (17.5–19.6) 18.2 (17.4–19.0)
BMI, kg/m², mean (SD) 23.3 (3.4) 23.3 (3.5) 23.3 (3.5)
OW, % (95% CI) 29.4 (28.0–30.7) 29.3 (28.0–30.5) 29.3 (28.4–30.2)
WHR, mean (SD) 0.51 (0.1) 0.52 (0.1) 0.51 (0.1)
High WHR, % (95% CI) 53.0 (51.6–54.5) 60.5 (59.1–61.8) 56.9 (55.9–57.9)
SBP, mm Hg, mean (SD) 126.0 (17.3) 123.7 (20.0) 124.8 (18.8)
DBP, mm Hg, mean (SD) 82.1 (11.0) 79.2 (11.3) 80.6 (11.3)
Hypertension, % (95% CI) 31.9 (30.6–33.3) 27.6 (26.4–28.9) 29.7 (28.7–30.6)
CRP, mg/L, mean (SD) 1.7 (1.9) 1.7 (2.0) 1.7 (1.9)
High CRP, % (95% CI) 20.8 (19.5–22.1) 21.8 (20.6–23.0) 21.3 (20.5–22.2)
HbA1c, %, mean (SD) 5.6 (0.9) 5.6 (0.9) 5.6 (0.9)
Fasting glucose, mg/dL, mean (SD) 98.3 (28.0) 96.0 (23.2) 97.0 (25.6)
T2DM, % (95% CI) 11.2 (10.2–12.2) 9.7 (8.9–10.6) 10.4 (9.8–11.1)
Fasting TC/HDL-C, mean (SD) 3.7 (1.3) 3.5 (1.1) 3.6 (1.2)
High TC/HDL-C, % (95% CI) 13.4 (12.4–14.5) 8.3 (7.5–9.1) 10.5 (9.8–11.2)
Fasting LDL-C, mg/dL, mean (SD) 113.1 (37.4) 117.7 (38.2) 115.5 (37.9)
High LDL-C, % (95% CI) 28.2 (26.8–29.6) 33.5 (32.1–34.9) 31.0 (30.0–32.0)
Fasting TG, mg/dL, mean (SD) 158.7 (152.4) 137.5 (110.1) 147.4 (132.1)
High TG, % (95% CI) 34.6 (33.1–36.1) 28.9 (27.5–30.2) 31.6 (30.6–32.6)
Urbanization index (maximum 120 points),* mean (SD) 67.3 (19.4) 67.8 (19.4) 67.5 (19.4)
Per capita household income, yuan, mean (SD) 12 904.1 (20 176.5) 11 914.9 (17 037.1) 12 386.2 (18 604.7)
Household asset score (maximum 11 points),† mean (SD) 6.1 (2.4) 6.1 (2.4) 6.1 (2.4)
Educational attainment (high school and above), % (95% CI) 28.7 (27.4–30.1) 20.8 (19.7–21.9) 24.6 (23.7–25.4)
BMI indicates body mass index; CHNS, Chinese Health and Nutrition Survey; CRP, high sensitivity C-reactive protein; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein
cholesterol; LDL-C, low-density cholesterol; OW, overweight; SBP systolic blood pressure; TC, total cholesterol; TG, triglycerides; T2DM, type 2 diabetes mellitus; WHR, waist
circumference/height ratio.
*Urbanization index is a 12-component scale with a maximum of 120 points that includes population density, economic activity, transportation infrastructure, sanitation, etc., to define and
distinguish urbanicity.33
†Asset score ranges from 0 to 11, with each asset (color TV, refrigerator, microwave oven, electric cooking pot, air conditioner, electric fan, computer, camera, telephone, cell phone, and
video disk player) worth 1 point.
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risk factors above risk factor thresholds also increased
from 2009 to 2015 in men aged 18 to 35, 35 to 50, and
50 to 65 years and in women aged 35 to 50 and 50 to
65 years.
Discussion
We observed a higher incidence of cardiometabolic risk
development in a recent population-based cohort of Chinese
adults from the CHNS compared with previous studies with 5
to 9 years of follow-up.14,18–20 These data portend an
increasing burden of CVD in Chinese adults, and CVD is
already the leading cause of death in China.2 In only 6 years
between 2009 and 2015, among women with cardiometabolic
risk factors below cardiometabolic risk thresholds in 2009, a
significant proportion of women (43.8%) developed high WHR,
24.9% developed hypertension, and 14.5% developed high
TC/HDL-C. The incidence of high WHR (42.4%) during the
same 6-year period was also high in men who had
cardiometabolic risk factors below cardiometabolic risk
thresholds in 2009, with 20.4% incident overweight and
Figure 2. Crude 2009 prevalence of cardiometabolic risk factors (95% CI) by age at 2009 in adult men and women. All P values for difference
across age groups <0.001. Hi CRP indicates high sensitivity C-reactive protein (3 mg/L to ≤10 mg/L); Hi LDL-C, high fasting low-density
lipoprotein cholesterol (≥130 mg/dL); Hi TC/HDL-C, high ratio of fasting total cholesterol to fasting high-density lipoprotein cholesterol (≥5); Hi
TG, high fasting triglycerides (≥150 mg/dL); Hi WHR, high waist circumference/height ratio (≥0.5); HTN, hypertension (systolic/diastolic blood
pressure ≥140/90 mm Hg or antihypertension medication); OW, overweight (body mass index ≥25); T2DM, type 2 diabetes mellitus (HbA1c
≥6.5%, fasting glucose ≥126 mg/dL, or diabetes mellitus medication).
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17.0% incident high TC/HDL-C. Furthermore, incident car-
diometabolic risk factors contributed to large proportions of
the 2015 prevalence of cardiometabolic risk factors. The
elevated total number of cardiometabolic risk factors in our
subsample analysis also demonstrated an increased burden of
cardiometabolic risk over time. In Chinese adults, overweight
is a strong risk factor for stroke and coronary heart disease
independent of age,34 hypertension is strongly associated
with elevated risk of and mortality from CVD,35 and TC/HDL-C
has high discriminatory power and even greater predictive
value for coronary heart disease than TC or HDL-C alone.31,36
The broad risk of high WHR in men and women across all age
groups is an additional concern for the cardiometabolic
disease burden in China, as WHR is superior to and
independent of BMI in predicting CVD.25,37 Our findings add
to the literature showing a temporal increase in WC at given
BMI from 1993 to 2009.38
Our findings also suggest strong age-related differences in
cardiometabolic risk within sex groups. Paralleling the pattern
of incident overweight, the incidence of high LDL-C and high
Figure 3. Inverse probability–weighted 2015 prevalence of cardiometabolic risk factors (95% CI) comprised incident and persistent
cases by age at 2015 in adult men and women. *P value for difference in prevalence across age groups, P<0.05; **P<0.01;
***P<0.001. Persistent was defined as having the cardiometabolic risk factor in 2009 and 2015. †P value for difference in
proportions of persistent cases, P<0.05; ††P<0.01; †††P<0.001. Incident was defined as having the cardiometabolic risk factor in
2015 but not in 2009. ‡P value for difference in proportions of incident cases, P<0.05; ‡‡P<0.01; ‡‡‡P<0.001. Hi CRP indicates high
high sensitivity C-reactive protein (3 mg/L to ≤10 mg/L); Hi LDL-C, high fasting low-density lipoprotein cholesterol (≥130 mg/dL);
Hi TC/HDL-C, high ratio of fasting total cholesterol to fasting high-density lipoprotein cholesterol (≥5); Hi TG, high fasting
triglycerides (≥150 mg/dL); Hi WHR, high waist circumference/height ratio (≥0.5); HTN, hypertension (systolic/diastolic blood
pressure ≥140/90 mm Hg or antihypertension medication); OW, overweight (body mass index ≥25); T2DM, type 2 diabetes mellitus
(HbA1c ≥6.5%, fasting glucose ≥126 mg/dL, or diabetes mellitus medication).
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triglycerides tended to be higher in younger men (aged 18–
50 years) than in older men (aged ≥50 years), portending
exacerbated future risk of CVD. Elevated cholesterol levels in
young men aged 18 to 39 years in 3 large US cohorts were
associated with excess long-term risk of CVD death.39 In
comparison, paralleling the pattern of incident high WHR,
incidence of high TC/HDL-C, high LDL-C, and high triglyc-
erides was generally higher in older women (aged ≥50 years)
than in younger women (aged 18–50 years). These age
differences in incidence of cardiometabolic risk may reflect
different associations between cardiometabolic risk factors
and obesity measures in men and women. Studies in
American Indians40 and Danish adults41,42 showed that,
compared with BMI, WC had a stronger association with lipid
profiles in women, whereas BMI was equally or more strongly
associated with lipid markers than WC in men. The different
patterns of incident abnormal lipid levels in our sample may
also relate to differential association between aging with lipid
profiles by sex. A study of Chinese Singaporeans aged 30 to
70 years43 suggested that lipid levels in men did not differ by
age group, whereas TC, LDL-C, and TC/HDL-C were higher in
older women (aged >50 years) than in younger women (aged
Figure 4. Inverse probability–weighted 6-year incidence of cardiometabolic risk factors (95% CI) from 2009 to 2015 by age at 2009 in adult men
andwomen. *P value for difference across age groups, P<0.05; **P<0.01; ***P<0.001. Hi CRP indicates high sensitivity C-reactive protein (3 mg/L
to ≤10 mg/L); Hi LDL-C, high fasting low-density lipoprotein cholesterol (≥130 mg/dL); Hi TC/HDL-C, high ratio of fasting total cholesterol to
fasting high-density lipoprotein cholesterol (≥5); Hi TG, high fasting triglycerides (≥150 mg/dL); Hi WHR, high waist circumference/height ratio
(≥0.5); HTN, hypertension (systolic/diastolic blood pressure ≥140/90 mm Hg or antihypertension medication); OW, overweight (body mass index
≥25); T2DM, type 2 diabetes mellitus (HbA1c ≥6.5%, fasting glucose ≥126 mg/dL, or diabetes mellitus medication).
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30–46 years). Moreover, the elevated incidence of high WHR,
type 2 diabetes mellitus, and abnormal lipid levels in women
aged >50 years in our sample may relate to hormonal changes
during perimenopause and menopause. Studies in Chinese
women44–46 found that menopause was associated with
increased central body fat, fasting glucose, HbA1c, TC, TC/
HDL-C, LDL-C, and triglycerides. In addition, the comparable
patterns of incident high WHR and incident type 2 diabetes
mellitus by age group in men and women in our study may
suggest a positive correlation between WHR and diabetes
mellitus, regardless of sex. Two large systematic reviews
showed that WHR was a stronger predictor for diabetes
mellitus than BMI.25,37 Furthermore, age-related differences in
prevalent cardiometabolic risk by sex groups were observed in
cross-sectional population-based studies of Chinese adults
from 2007 to 2012.10,47,48 Similar to our study, the results of
these studies suggest that the prevalence of abnormal lipid
levels and diabetes mellitus increased with age in women,
whereas the prevalence of abnormal lipid levels tended to be
highest in middle-agedmen (aged 40–60 years), paralleling the
prevalence of overweight.10,47,48 Our study adds incidence
data for a much wider range of cardiometabolic risk factors in a
diverse, population-based cohort reflecting urban and rural
communities across 9 provinces in China.
China has the greatest absolute disease burden of diabetes
mellitus5 and hypertension7 in the world. We documented
6-year incidence of type 2 diabetes mellitus of 7.9% in men and
6.3% in women, similar to the incidence of type 2 diabetes
mellitus in the Hong Kong Cardiovascular Risk Factor Preva-
lence Study during a median follow-up of 6.4 years from 1995
to 2004 (7.1%; 120 new cases of type 2 diabetes mellitus
among 1679 adults)15 but higher than the incidence of self-
reported type 2 diabetes mellitus from the Shanghai Women’s
Health Study during an average follow-up of 5 years from 1996
to 2004 (2.5%; 1608 new cases of type 2 diabetes mellitus
among 64 227 women)17 and the Shanghai Men’s Health
Study during an average follow-up of 5.4 years from 2002 to
2011 (2.5%; 1304 new cases of type 2 diabetes mellitus among
51 464 men).16 These differences may reflect underreporting
in self-reported type 2 diabetes mellitus compared with our
measured data and may be due to the more homogeneous
sample compared with our diverse population-based sample. A
few large population-based studies have reported type 2
diabetes mellitus incidence in China over 7 to 9 years. A
combined study based on the China Multicenter Collaborative
Study of Cardiovascular Epidemiology and the China Cardio-
vascular Health Study reported an age-standardized type 2
diabetes mellitus incidence rate of 9.5 and 9.2 per 1000
person-years in men and women, respectively, from 1998 to
2008 during an average 8-year follow-up.18 Among 500,000
participants in the China Kadoorie Biobank Study launched in
2004, the incidence of type 2 diabetes mellitus was 2.8 and 3.1
per 1000 person-years during 7 years (last follow-up in 2014)
and 9 years (last follow-up in 2016) of follow-up, respec-
tively.19,20 Our study contributes to this literature over a more
recent time frame. In addition, we found higher incidence of
type 2 diabetes mellitus than the earlier studies, thus our
findings suggest an increase in type 2 diabetes mellitus in
China over the past decade. We have shown elsewhere that a
substantial proportion of Chinese adults have undiagnosed
hypertension and diabetes mellitus.49 The 6-year incidence of
hypertension in our sample (29.2% in men, 24.9% in women) is
similar to the 8-year incidence of hypertension from the China
National Hypertension Survey of adults aged ≥40 years from
1991 to 2000 (28.9% in men, 26.9% in women),14 despite the
shorter follow-up in the CHNS, suggesting an increase in
hypertension risk over the past 2 decades. Indeed, a recent
study from the CHNS13 showed that hypertension incidence
increased from 1991–1997 to 2004–2009, especially in young
adults (aged 18–39 years). Consistent with our findings, the
1991 China National Hypertension Survey14 also documented
an increase in hypertension incidence with age. Aging is an
independent risk factor for arterial stiffening,50 which was
found to be associated with higher incident hypertension in the
FraminghamOffspring study51 and to precede the development
of hypertension in a diet-induced obese mouse model.52
This study has some limitations. First, we documented large
loss to follow-up from 2009 to 2015 (40.7%). To address
potential selection bias, we used IPW to account for loss to
follow-up assuming that loss to follow-up was dependent on
the selected baseline predictors.21 The use of IPW allowed us
to generalize our results to 6-year incidence and 2015
prevalence of cardiometabolic risk factors in the full 2009
analysis sample (Table S2). Second, we used conventional
cutoff points for cardiometabolic risk factors to allow for
comparison across countries, but this approach may not reflect
the true risks for Chinese adults, especially for overweight.
There is disagreement about the optimal cutoff points for
overweight in Chinese populations, with some advocating
lower cutoff points53,54 than the WHO cutoff point (BMI 25),24
whereas others support the WHO cutoff point.55–57 For
comparison with Asian populations, we also reported the
prevalence and incidence of overweight from 2009 to 2015
defined by the Asian cutoff point (BMI 23)24 (Tables S1, S3, S4).
Moreover, we acknowledge that defining cardiometabolic risk
factors by cutoff points could result in false-negative and false-
positive incident cases due to small variations near the cutoff
points. The media has the potential to play an important role in
controlling cardiometabolic risk factors. Some national cam-
paigns have addressed lifestyles in China (eg, China Healthy
Lifestyle for All campaign),58 but we do not have data on the
effects of such campaigns.
The strengths of our study include the prospective design,
which allows incident estimation of elevated cardiometabolic
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risk factors, the collection of various biomarkers, and the
representation of a wide age range of adults, multiple
geographical regions, and diverse rural and urban communities.
Our findings from the population-based cohort of the CHNS
underscore the substantial cardiometabolic risks among Chi-
nese adults, provide evidence for differential patterns of
cardiometabolic risk by sex and age groups, and foreshadow
the increasing burden of cardiometabolic diseases in China.
The observed higher incidence of cardiometabolic risk among
young Chinese adult men and women relative to that found in
other countries parallels increasing trends in obesity in China
over the past decade. This represents a major concern for the
future of Chinese health and the healthcare system and
portends lengthy treatment, higher costs, and early disability.
Given that rapid urbanization has affected China over the past 3
decades, understanding the cardiometabolic risks in China has
huge implications for other low- to middle-income countries
that are entering or experiencing the same rapid increase in
urbanization.
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Table S1. Crude 2009 prevalence of cardiometabolic risk factors by age at 2009 in men and women, percent (95% Confidence Interval). 












































































































Total 29.4 51.1 53.0 31.9 20.8 11.2 13.4 28.2 34.6 
(28.0, 30.7) (49.6, 52.5) (51.6, 54.5) (30.6, 33.3) (19.5, 22.1) (10.2, 12.2) (12.4, 14.5) (26.8, 29.6) (33.1, 36.1) 
P-value† <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Women 



























































































P-value† <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
*or medication;
†p-value for difference across age groups. 
Table S2. Association of baseline characteristics [parameter estimates (95% confidence interval)] with likelihood of being lost to 


















































































Age squared 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
(0.00, 0.00) (0.00, 0.00) (0.00, 0.00) (0.00, 0.00) (0.00, 0.00) (0.00, 0.00) (0.00, 0.00) (0.00, 0.00) 





































































Below high school Ref. - - - - - - - 


















Per capita household income 
Low Ref. - - - - - - - 
Middle 0.00 0.00 -0.02 -0.03 -0.05 -0.00 -0.00 -0.00


























































































































Hunan 0.18 0.18 0.10 0.11 0.18 0.30 0.30 0.30 



































*Probit model predicting loss to follow-up from 2009 to 2015 for each of the cardiometabolic risk factors, versus remaining in the
study, controlling for sex, age, squared age, sex and age interaction, sex and squared age interaction, urbanization level, educational 
attainment, income level, household asset score, province, and the given cardiometabolic risk factor in 2009. 
†Or medication. 
‡Each of the cardiometabolic risk factors in 2009 was included in the model predicting its own lost to follow-up. For example, 
overweight was in the model predicting the likelihood of missing 2015 overweight data among individuals who had 2009 overweight 
data. 
§Urbanization index, a 12-component scale with a maximum of 120 points that includes population density, economic activity,
transportation infrastructure, sanitation, etc., to define and distinguish urbanicity,1 was categorized by tertiles. 
||Household asset score ranges 0-11, with each asset (color TV, refrigerator, microwave oven, electrical cooking pot, air conditioner, 
electric fan, computer, camera, telephone, cell phone and VCD/DVD) worth 1 point. 
Table S3. Inverse probability weighted 2015 prevalence of cardiometabolic risk factors by age at 2015 among men and women, percent 













































































































Total 38.9 59.5 65.2 42.4 10.2 14.2 22.2 35.5 29.0 
(36.9, 40.8) (57.5, 61.5) (63.2, 67.1) (40.4, 44.5) (8.8, 11.8) (12.8, 15.8) (20.2, 24.4) (33.1, 38.0) (26.7, 31.3) 
P-value† <0.001 <0.001 0.001 <0.001 0.002 <0.001 0.110 0.014 <0.001 
Women 



























































































P-value† 0.002 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
*or medication;
†p-value for difference across age groups. 
Table S4. Inverse probability weighted 6-year incidence of cardiometabolic risk factors from 2009 to 2015 by age at 2009 in men and 
































































































































P-value† <0.001 <0.001 0.141 <0.001 0.175 0.051 0.132 0.016 <0.001 
Women 



























































































P-value† 0.182 0.247 <0.001 <0.001 0.236 <0.001 0.002 <0.001 <0.001 
*or medication;
†p-value for difference across age groups.
Table S5. The total number of cardiometabolic risk factors above risk factor thresholds [mean (standard 
deviation)] by sex and age in a subsample of China Health and Nutrition Survey participants seen in 2009 
and 2015 with data for all cardiometabolic risk factors (n=3,260). 
Age in 2009 N 2009 2015 P-value*
Men 
18-35y 154 1.61 (1.55) 2.32 (1.87) <0.001 
35-50y 471 2.25 (1.77) 2.71 (1.79) <0.001 
50-65y 590 2.29 (1.69) 2.59 (1.78) 0.003 
≥65y 224 2.43 (1.61) 2.71 (1.58) 0.07 
Total 1,439 2.23 (1.70) 2.62 (1.76) <0.001 
Women 
18-35y 191 1.05 (1.33) 1.27 (1.39) 0.124 
35-50y 662 1.73 (1.52) 2.22 (1.67) <0.001 
50-65y 729 2.80 (1.67) 3.06 (1.78) 0.005 
≥65y 239 3.13 (1.76) 3.30 (1.73) 0.271 
Total 1,821 2.27 (1.74) 2.60 (1.81) <0.001 
*P-value for a paired t-test comparing the total number of cardiometabolic risk factors above thresholds between wave 2009 and
2015 by sex and age groups. 
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